Cost-Effectiveness of Rifaximin/alpha versus Lactulose in preventing recurrent episodes of overt hepatic encephalopathy: a systematic review and meta-analysis

Category Systematic review
ConferenceThe International Liver Congress
Year 2021
This article has no abstract
Epistemonikos ID: b2458083eaa0d58c7016d4e22d08fa6d83423d20
First added on: Sep 10, 2025